Navigation Links
GTSI Wins Department of Defense Contract to Provide Biometric Automated Toolset Systems for U.S. Army
Date:8/5/2011

HERNDON, Va., Aug. 5, 2011 /PRNewswire/ -- GTSI Corp. (NASDAQ: GTSI), a leading information technology systems integrator for federal, state and local governments, announced today the award of the Biometric Automated Toolset-Army (BAT-A) contract by the U.S. Army.  This contract will provide war fighters mobile biometric devices to assist in real-time identification of persons of interest in the field. The contract has a total value of $159 million. The award covers a 16-month period and will be executed as part of GTSI's Information Technology Enterprise Solutions – 2 Hardware (ITES-2H) contract with the federal government.

(Logo: http://photos.prnewswire.com/prnh/20070712/GTSILOGO)

Biometrics are measurable physical characteristics such as fingerprints, iris scans, facial recognition, hand geometry, palm prints, handwriting, voice, and DNA. DoD biometric systems capture, transmit, store, share, retrieve, exploit and display biometric data for timely identification and verification. These systems are mission enablers for force protection, intelligence, physical and logical access control, as well as identity management and credentialing, law enforcement, and interception operations. GTSI partnered with Cross Match Technologies, Inc., a leading manufacturer of biometric solutions, to deliver a portable solution that provides a rugged platform capable of capturing multiple biometric modalities in the field.

BAT-A includes an enrollment kit consisting of a laptop and attached biometric collection devices capable of enrollment, verification, and identity detection, together with mobile handheld devices for collecting, storing, and uploading pertinent data to U.S. Army biometrics collection centers. A system of servers containing the biometric database maintains and synchronizes information, ensuring that data collected at one location is available a
'/>"/>

SOURCE GTSI Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. NJIT receives second part of $1M gift to chemical engineering department
2. Story tips from the Department of Energys Oak Ridge National Laboratory, June 2011
3. Story tips from the US Department of Energys Oak Ridge National Laboratory March 2011
4. Story tips from the Department of Energys Oak Ridge National Laboratory January 2011
5. Story tips from the Department of Energys Oak Ridge National Laboratory -- December 2010
6. Clemson researcher will study plutonium underground for Energy Department
7. Story tips from the US Department of Energys Oak Ridge National Laboratory October 2010
8. The GW Department of Biochemistry and Molecular Biology to host Nobel Laureate Dr. Ferid Murad
9. Story tips from the US Department of Energys Oak Ridge National Laboratory, September 2010
10. Story tips from the Department of Energys Oak Ridge National Laboratory, August 2010
11. Story tips from the Department of Energys Oak Ridge National Laboratory July 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2015)... , Feb. 18, 2015  Cepheid (NASDAQ: ... at the following conferences, and invited investors to participate via ... Boston, MA Tuesday, March 3, 2015 at ... Conference, Orlando, FL Wednesday, March 4, ... Webcasts To access the live webcasts for these events, please ...
(Date:2/11/2015)... February 11, 2015 ... "Access Control Market by Product (Cards and Readers, Biometrics, ... Defense, Government, Industrial, Healthcare, Education) and By Geography - Global ... MarketsandMarkets, the Access Control Market is expected ... at a CAGR of 10.6% between 2014 ...
(Date:2/5/2015)... 2015  Marken is starting its 35 th ... a new marketing campaign to solidify its place as ... campaign focuses on First as a primary ... The first headline in the series, ... its client,s priorities. Marken recognizes the need to protect ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... The ongoing dance between a virus and ... human adenoviruses typically cause mild infections, recent reports have ... fatal, human infections. Researchers from the Massachusetts ... for Public Health, School of Systems Biology, George Mason ...
... balls that can zap pain and lung tumors to ... physicians will present the latest research on cutting-edge treatments ... Meeting April 13󈝾 at the Ernest N. Morial Convention ... the theme "IR Reaching Out" and delivers education, resources ...
... have identified a new potential therapeutic target for lowering ... to statins. Scientists in the lab of ... action of a gene responsible for transporting a protein ... remove cholesterol from the blood in mice. Trapping the ...
Cached Biology News:Society of Interventional Radiology: 38th Annual Scientific Meeting 2U-M researchers find new way to clear cholesterol from the blood 2
(Date:3/2/2015)... , March 2, 2015  Pfenex Inc. (NYSE ... the development of biosimilar therapeutics, today announced that ... Global Healthcare Conference in Miami, FL at the Loews Miami ... executive officer of Pfenex, will provide an overview ... on March 12th at 9:00 am ET. A live audio webcast ...
(Date:3/2/2015)... YORK , March 2, 2015 ... scroll to bottom.   Moments ago, Analysts ... including Sunshine Heart (NASDAQ: SSH ), ... ), Syneron Medical (NASDAQ: ELOS ), Spectranetics (NASDAQ: ... ). Analysts Review provides a single unified platform for investors, ...
(Date:3/2/2015)... , March 2, 2015 VG ... developing therapies for autoimmune and infectious diseases, announced ... has issued an important new composition of matter ... through the targeting of CLIP. ... technology underlying VG Life Sciences, VG1177, a synthetic ...
(Date:3/2/2015)... March 02, 2015 Global ... formed alliance with Shenzhen HANK Bioengineering Co., Ltd. ... The alliance will establish a stem cells training ... China in September 2015. , Shenzhen HANK is ... an award-winning scientist, microbiologist and virologist, to integrate ...
Breaking Biology Technology:Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4VG Life Sciences Granted Key Composition Of Matter Patent 2VG Life Sciences Granted Key Composition Of Matter Patent 3Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3
... Avastin(R) May Slow Tumor Growth, ROCKVILLE, ... ENMD ), a clinical-stage pharmaceutical company developing,therapeutics ... diseases, today,announced the presentation of interim results ... NCD with Avastin(R) (bevacizumab) in patients,with advanced ...
... Sanofi-aventis announced,today that the anticoagulant Clexane(R) (enoxaparin ... Japan by the Ministry of Health, Labour ... (VTE) in patients,undergoing orthopaedic surgery of the ... knee replacement and hip fracture surgery., ...
... Forest Laboratories, Inc.,(NYSE: FRX ), Forest Laboratories ... Merz Pharmaceuticals GmbH announced that they have filed ... the District of Delaware against,additional companies for infringement ... relates to Forest,s Namenda(R) product. The defendants,named in ...
Cached Biology Technology:EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 2EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 3EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 4Clexane(R)/Lovenox(R) Approved in Japan 2Clexane(R)/Lovenox(R) Approved in Japan 3Clexane(R)/Lovenox(R) Approved in Japan 4Clexane(R)/Lovenox(R) Approved in Japan 5Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement 2
Cag-A (IgG) -Ab EIA Sample Size: 10 l...
... Inhibitor is a potent noncompetitive ... as RNase A. Like other ... Inhibitor is an acidic protein ... kDa. RNaseOUT inhibits RNase A ...
... Inhibitor (Ribonuclease inhibitor) is a ... to inhibit RNase activity. It ... endonuclease activity. , Inhibits ... RNA template , Lacks ...
Canine Aortic Smooth Muscle Cells (CnAOSMC) (>500,000 cells)...
Biology Products: